Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Total Liabilities (2012 - 2026)

Updated

Grace Therapeutics' Total Liabilities came in at $2.22 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 41.0% from $3.76 million a year earlier but up 19.1% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Total Liabilities (2012 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Grace Therapeutics' Total Liabilities was $2.76 million, down 48.8% from FY2025.

  • Total Liabilities carries a five-year compound annual growth rate of -16.5% (FY2021 to FY2026).
  • Going back by fiscal year, Total Liabilities was $5.38 million in FY2025 (-53.4%), $11.56 million in FY2024 (+3.5%), $11.17 million in FY2023 (-45.1%) and $20.35 million in FY2022 (+199.4%).
  • The five-year range for quarterly Total Liabilities is $1.86 million (fiscal Q1 2027) to $20.75 million (fiscal Q2 2023).
  • Year-over-year, Total Liabilities has declined for nine consecutive quarters, with an average decline of 49.2% over the last eight quarters.
  • The fastest year-over-year change in Total Liabilities over five years came in fiscal Q3 2023 (growth of 534.5%), and the weakest in fiscal Q1 2027 (a decline of 70.2%).
  • Business Quant data shows GRCE's Total Liabilities at $1.86 million (Q1 2027), $2.76 million (Q4 2026) and $3.6 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn 107.80 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn 115.90 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn 152.26 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn 87.83 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn - -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn 68.11 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn 81.70 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn 38.37 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn 115.70 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn - 2.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 2.22 Mn
Jun 30, 2026 1.86 Mn
Mar 31, 2026 2.76 Mn
Dec 31, 2025 3.60 Mn
Sep 30, 2025 3.76 Mn
Jun 30, 2025 6.26 Mn
Mar 31, 2025 5.38 Mn
Dec 31, 2024 9.09 Mn
Sep 30, 2024 9.22 Mn
Jun 30, 2024 10.35 Mn
Mar 31, 2024 11.56 Mn
Dec 31, 2023 11.51 Mn
Sep 30, 2023 11.47 Mn
Jun 30, 2023 9.02 Mn
Mar 31, 2023 11.17 Mn
Dec 31, 2022 20.08 Mn
Sep 30, 2022 20.75 Mn
Jun 30, 2022 20.53 Mn
Mar 31, 2022 20.35 Mn
Dec 31, 2021 3.17 Mn
API Access

Grace Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=GRCE&period=max&api_key=YOUR_API_KEY